Monkeypox and oral lesions associated with its occurrence: a systematic review and meta-analysis
暂无分享,去创建一个
F. Akhter | H. Abutayyem | Mohammad Khursheed Alam | Ashwini Dhopte | Okba Mahmoud | M. Shayeb | Ferdous Bukhary | Hiroj Bagde | Naif Momenah | Krishnanand Shetty
[1] Sharmistha Mishra,et al. Human monkeypox: cutaneous lesions in 8 patients in Canada , 2022, Canadian Medical Association Journal.
[2] A. Iamaroon. Oral manifestations of monkeypox: Brief review. , 2022, Dental and medical problems.
[3] J. Foy,et al. Monkeypox oral lesions , 2022, Journal of stomatology, oral and maxillofacial surgery.
[4] A. Tanuri,et al. Unusual epidemiological presentation of the first reports of monkeypox in a low-income region of Brazil , 2022, Travel medicine and infectious disease.
[5] P. Ortiz-Romero,et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study , 2022, The Lancet.
[6] L. Samaranayake,et al. The Monkeypox Outbreak and Implications for Dental Practice , 2022, International dental journal.
[7] S. Peters,et al. Oral Manifestations of Monkeypox: A Report of 2 Cases , 2022, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[8] D. Patil,et al. First two cases of Monkeypox virus infection in travellers returned from UAE to India, July 2022 , 2022, The Journal of infection.
[9] D. Chilton,et al. Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series , 2022, BMJ.
[10] A. Antinori,et al. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. , 2022, The New England journal of medicine.
[11] Markus H. Antwerpen,et al. Clinical and virological features of first human monkeypox cases in Germany , 2022, Infection.
[12] J. Blanco,et al. Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[13] R. Byrne,et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis , 2022, The Lancet. Infectious diseases.
[14] Allen Cheng,et al. Monkeypox infection presenting as genital rash, Australia, May 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[15] E. Nicastri,et al. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[16] C. Akdis,et al. Monkeypox outbreak in Europe, UK, North America, and Australia: A changing trend of a zoonotic disease , 2022, Allergy.
[17] G. Wortmann,et al. Imported Monkeypox from International Traveler, Maryland, USA, 2021 , 2022, Emerging infectious diseases.
[18] F. Lienert,et al. The changing epidemiology of human monkeypox—A potential threat? A systematic review , 2021, medRxiv.
[19] E. Mayo-Wilson,et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews , 2021, PLoS medicine.
[20] Andrew T. Russo,et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications , 2020, Expert review of anti-infective therapy.
[21] M. Koopmans,et al. Human Monkeypox , 2019, Infectious Disease Clinics of North America.
[22] R. Lin,et al. A case of imported Monkeypox in Singapore , 2019, The Lancet Infectious Diseases.
[23] Anna M. Mandra,et al. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report , 2019, The Lancet. Infectious diseases.
[24] D. Hruby,et al. Oral Tecovirimat for the Treatment of Smallpox , 2018, The New England journal of medicine.
[25] P. Tugwell,et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both , 2017, British Medical Journal.
[26] Marion E. Morrison,et al. Short‐term clinical safety profile of brincidofovir: A favorable benefit–risk proposition in the treatment of smallpox , 2017, Antiviral research.
[27] G. Painter,et al. Development of CMX001 for the Treatment of Poxvirus Infections , 2010, Viruses.
[28] D. Smee. Progress in the Discovery of Compounds Inhibiting Orthopoxviruses in Animal Models , 2008, Antiviral chemistry & chemotherapy.
[29] R. Jordan,et al. Efficacy of Delayed Treatment with ST-246 Given Orally against Systemic Orthopoxvirus Infections in Mice , 2006, Antimicrobial Agents and Chemotherapy.
[30] R. Wittek. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. , 2006, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[31] J. Morgenstern,et al. Monkeypox , 1987, Air medical journal.
[32] A. Morand,et al. Review of poxvirus: emergence of monkeypox. , 2017, Medecine et sante tropicales.